---
title: "Core Scientific tumbles 8%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305696130.md"
description: "Core Scientific fell 8.06% to US$13.35. Down 44.84% over six months and down 8.28% YTD."
datetime: "2026-11-16T15:35:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305696130.md)
  - [en](https://longbridge.com/en/news/305696130.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305696130.md)
generator: "portal-rs"
---

# Core Scientific tumbles 8%

Core Scientific (CORZ.US) tumbled more than **8%** during regular trading to **$13.35**.

The stock is down 44.84% over the past six months and down 8.28% year to date. It sits 56.17% below its 52-week high of US$30.46. Volume was 2.66 times its average.

The Nasdaq Composite is down 2.44% over the past five sessions and up 6.00% year to date.

The application software industry index fell 1.7% over the same period.

The company recently sold 816 bitcoins to fund capital expenditures and other cash needs, leaving it with a holding of 32 bitcoins as it pivots toward building AI data centers.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [CORZ.US](https://longbridge.com/en/quote/CORZ.US.md)
- [COZX.US](https://longbridge.com/en/quote/COZX.US.md)

## Related News & Research

- [Core Scientific (CORZ) Could Be 6% Overvalued Following Strong Q3 Earnings](https://longbridge.com/en/news/305813509.md)
- [Should Earnings Beat Require Action From Core Scientific (CORZ) Investors?](https://longbridge.com/en/news/306226171.md)
- [Core Scientific Chief Legal and Administrative Officer Todd DuChene Reports Sale of $135,570 in Common Shares](https://longbridge.com/en/news/306017266.md)
- [BUZZ-Hedge fund Situational Awareness sharply trims stakes in AI, data center firms in Q3](https://longbridge.com/en/news/305811400.md)
- [Core Scientific management says capacity additions drive nearly 60% sequential growth in Q3 2026 colocation revenue](https://longbridge.com/en/news/305031010.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**